Person Prof Harald Schmidt National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects Participant in Anti-atherosclerotic effects of angiotensin fragments & non-AT1 receptors: Validation as innovative therapeutic targets (funded by National Health and Medical Research Council) Participant in Defining the roles of NADPH oxidases in vascular remodelling and arterial hypertension (funded by National Health and Medical Research Council) Participant in Heme-oxidised soluble guanylyl cyclase, a mechanism-based target for vascular diagnostics and vasoprotective therapy (funded by National Health and Medical Research Council) Principal investigator of, Participant in Identification of the pathophysiologically relevant NADPH oxidase isoform in human cardiovascular disease - role of NOX5 (funded by National Health and Medical Research Council) Participant in Inhibition of specific NOX isoforms as a new treatment for hypertensive and diabetic retinopathy (funded by National Health and Medical Research Council) View all 9 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects Participant in Anti-atherosclerotic effects of angiotensin fragments & non-AT1 receptors: Validation as innovative therapeutic targets (funded by National Health and Medical Research Council) Participant in Defining the roles of NADPH oxidases in vascular remodelling and arterial hypertension (funded by National Health and Medical Research Council) Participant in Heme-oxidised soluble guanylyl cyclase, a mechanism-based target for vascular diagnostics and vasoprotective therapy (funded by National Health and Medical Research Council) Principal investigator of, Participant in Identification of the pathophysiologically relevant NADPH oxidase isoform in human cardiovascular disease - role of NOX5 (funded by National Health and Medical Research Council) Participant in Inhibition of specific NOX isoforms as a new treatment for hypertensive and diabetic retinopathy (funded by National Health and Medical Research Council) View all 9 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover
